MedTrace Logo

Investigating tDCS as a Treatment for Unipolar and Bipolar Depression

NCT01562184 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2015-12-02

No results posted yet for this study

Summary

Transcranial direct current stimulation (tDCS) is a novel treatment approach for depression that has shown promising efficacy in four recent double-blind, randomized, sham-controlled trials (RCT) and a meta-analysis. This study is a RCT of tDCS in depressed patients, testing its efficacy in both unipolar and bipolar depression. Mood, cognitive test performance and biomarkers will be measured during the trial.

Conditions

Interventions

DEVICE

Sham tDCS device

Sham tDCS

DEVICE

Soterix tDCS device

Active tDCS

Sponsors & Collaborators

  • Duke University

    collaborator OTHER

  • Emory University

    collaborator OTHER

  • Sheppard Pratt Health System

    collaborator OTHER

  • University of Medicine and Dentistry of New Jersey

    collaborator OTHER

  • University of Texas

    collaborator OTHER

  • The University of New South Wales

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United States
  • Australia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01562184 on ClinicalTrials.gov